Haiyang Yu
- Molecular Biology
- Oncology top 10%
- Cancer Research top 5%
- Immunology
- Pulmonary and Respiratory Medicine
- Topics
- Cancer-related Molecular Pathways (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)Microtubule and mitosis dynamics (3 papers)
- Journals
- Nature CommunicationsCell Death and DifferentiationInternational Journal of Biological Macromolecules
- Partner nations
- ChinaUnited States
In The Last Decade
Haiyang Yu
16 papers receiving 854 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 547
- Oncology 440
- Cancer Research 368
- Immunology 111
- Pulmonary and Respiratory Medicine 67
Countries citing papers authored by Haiyang Yu
This map shows the geographic impact of Haiyang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyang Yu more than expected).
Fields of papers citing papers by Haiyang Yu
This network shows the impact of papers produced by Haiyang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyang Yu. The network helps show where Haiyang Yu may publish in the future.
Co-authorship network of co-authors of Haiyang Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Haiyang Yu. A scholar is included among the top collaborators of Haiyang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyang Yu. Haiyang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 41 | |
| 9 | 38 | |
| 10 | LIF is a new p53 negative regulator. | 14 |
| 11 | 11 | |
| 12 | 12 | |
| 13 | 154 | |
| 14 | 130 | |
| 15 | 95 | |
| 16 | 351 | |
| 17 | 2 |
About Haiyang Yu
Haiyang Yu is a scholar working on Cancer Research, Oncology and Immunology, having authored 17 papers that have together received 861 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Microtubule and mitosis dynamics (3 papers). The work is most often cited by research in Cancer Research (368 citations), Oncology (440 citations) and Molecular Biology (547 citations). Haiyang Yu has collaborated with scholars based in China and United States. Frequent co-authors include Wenwei Hu, Yuhan Zhao, Cen Zhang, Zhaohui Feng, Meihua Lin, Lianxin Liu, Rui Wu, Xuehui Hong, Arnold J. Levine and Juan Liu. Their work appears in journals such as Nature Communications, Cell Death and Differentiation and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.